AIT-082; A DRUG FOR TREATMENT OF ALZHEIMER'S DISEASE

Award Information

Agency: Department of Health and Human Services	Branch: N/A	Award ID: 16260	Program Year/Program: 1993 / SBIR
Agency Tracking Number: 16260	Solicitation Year: N/A	Solicitation Topic Code: N/A	Solicitation Number: N/A

Small Business Information: Advanced Immunotherapeutics
2691 Richter Avenue, Suite 105 Irvine, CA 92714
View profile »

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No

Phase 2: Fiscal Year: 1993

Title: AIT-082; A DRUG FOR TREATMENT OF ALZHEIMER'S DISEASE

Agency: HHS

Contract: N/A

Award Amount: $478,811.00

Abstract:
WE WILL DEVELOP AIT-082 FOR THE TREATMENT OF DEMENTIA DUE TO ALZHEIMER'S DISEASE, STROKE OR AGING. IN PHASE I, WE PLAN TO COMPLETE THE PRECLINICAL STUDIES NEEDED TO SUBMIT AN INVESTIGATION- AL NEW DRUG (IND) EXEMPTION APPLICATION TO THE FOOD AND DRUG ADMINISTRATION (FDA). SPECIFICALLY, WE WILL: (1) DETERMINE THE PRECLINICAL PHARMACODYNAMICS/ PHARMACOKINETICS OF AIT-082, (2) CONDUCT PRECLINICAL TOXICOLOGICAL TESTING, AND (3) CONDUCT ADDITIONAL PRECLINICAL STUDIES ON THE MECHANISM OF ACTION OF AIT- 082. THE AIM OF PHASE II WILL BE TO FILE AN IND APPLICATION AND TO ESTABLISH THE CLINICAL SAFETY AND EFFICACY OF AIT-082.

Principal Investigator:
Glasky, Alvin J
Principal Investigator
7147562230

Business Contact:
1 r43 ag09911-01

Small Business Information at Submission:

Advanced Immunotherapeutics
2691 Richter Avenue, Suite 105 Irvine, CA 92714

EIN/Tax ID:

DUNS: N/A

Number of Employees: N/A

Woman-Owned: No

Minority-Owned: No

HUBZone-Owned: No